Division of Endocrinology & Diabetes

Required Training Activities

In addition to rotations and conferences, first-year fellows are required to attend four specialized training activities.

  1. Endocrinology Clinical Laboratory

    The Endocrinology Clinical Laboratory is located on the West Campus and is supervised by the Laboratory Director, Dr. Martin I. Surks. The laboratory carries out most of the endocrinology measurements for the Medical Center, more than 50,000 determinations per year. Fellows will receive a lecture on the methodology of endocrine determinations. This will include the principles of radio-immunoassay and immunophotoluminescence assays. Practical experience in development of normal ranges, hook effects, standard curves, etc., will be reviewed.
  2. Bone Biopsy

    The Division of Nephrology has an active bone biopsy program on the West Campus of the Medical Center. Maria Coco, M.D., Assistant Professor of Medicine, supervises this activity. Fellows may spend up to 4 - 8 hours with Dr. Coco learning the indications and interpretations of bone biopsy for different metabolic bone diseases.
  3. Thyroid Aspiration Cytology

    Fellows will learn and carry out thyroid sonography and ultrasound-guided aspiration biopsy. Fellows will have a number of sessions with Dr. Antonio Cajigas, M.D., Division of Cytology at the Medical Center and Associate Professor of Pathology. These sessions will include basic aspects of interpretation of aspiration smears. Fellows are expected to learn the principles of aspiration cytology of thyroid tissue.
  4. Nuclear Medicine

    Fellows will receive 2 lectures on the principles of nuclear diagnostic testing as well as radiation safety. Amiel Rudavsky, M.D., a member of the Division and Associate Professor of Medicine and Nuclear Medicine, will give the lectures. In addition, fellows will observe radioactive iodine uptake and scans in the Department of Nuclear Medicine. They will also attend the Nuclear Medicine Board at least four times. The Nuclear Medicine Board interprets data, examines patients, and makes decisions concerning the use of radioactive iodine and dosimetry in patients with hyperthyroidism.
Click here to log in